pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

TAG: Series A

Jul 20, 2023

EpiBiologics Appoints Ann Lee-Karlon as Chief Executive Officer and President, Extends Series A Financing to Over $70 Million

Jul 19, 2023

KayoThera, Inc. Strengthens Financial Position with $5.2 Million in Grant and Expanded Series A Funding, Bringing Total Financial Support to $14 Million

Jun 7, 2023

Mozart Therapeutics Raises $25 Million in Expanded Series A Financing to Support Clinical Development of First-in-Class CD8 Treg Modulators for the Treatment of Autoimmune Diseases

May 17, 2023

Indapta Therapeutics Announces U.S. FDA Clearance of IND for IDP-023, an Allogeneic Natural Killer (NK) Cell Therapy for Cancer

Apr 26, 2023

Scottish Biotech ILC Therapeutics Sets Sights on Series A and IPO After Recent Investment Round

Apr 17, 2023

Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases

Mar 22, 2023

EpiBiologics Launches with $50 million Series A Financing to Advance Next-Generation Protein Degradation Platform

Mar 7, 2023

Volastra Therapeutics In-Licenses Clinical Stage KIF18A Inhibitor and Secures $60 Million in Series A Funding to Further Advance Cancer-Focused Pipeline

Mar 7, 2023

Rapport Therapeutics Launches with $100 Million to Transform the Treatment of Neurological Disease through the Discovery and Development of Precision Therapies

Feb 23, 2023

Olatec Therapeutics Announces the Final Closing, Led by Sanders Morris Harris, on Its $40 Million Series A Financing Round

Feb 23, 2023

Transcend Therapeutics, a mental health-focused biotechnology company, announces Series A funding round of $40 million led by Alpha Wave Global and Integrated Investment Partners

Feb 1, 2023

Ratio Therapeutics Announces $20M Series A Financing to Advance Targeted Radiotherapies for Cancer Treatment

Jan 9, 2023

LinKinVax Just Completed a New Round of Financing, Initiated in 2022, for a Total of €7,3 M

Dec 8, 2022

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Dec 8, 2022

Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors

Dec 6, 2022

Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement

Dec 6, 2022

4BIO Capital Portfolio Company Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement

Dec 5, 2022

SonoThera™ Completes $60.75M Series A Funding for Ultrasound-Guided, Nonviral Gene Therapy Platform Development

Nov 30, 2022

Nectin Therapeutics Announces Extended Series A Financing to Over $25M and Initiation of Patient Dosing in Phase 1 Clinical Trial of NTX1088, First-in-Class Anti-PVR Targeted Immunotherapy for Treatment of Patients with Advanced Solid Tumors USA - English USA - English

Nov 30, 2022

Nectin Therapeutics Announces Extended Series A Financing to Over $25M and Initiation of Patient Dosing in Phase 1 Clinical Trial of NTX1088, First-in-Class Anti-PVR Targeted Immunotherapy for Treatment of Patients with Advanced Solid Tumors

Nov 29, 2022

Rgenta Therapeutics Raises $52M in Series A Financing

Nov 10, 2022

Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M

Nov 4, 2022

hC Bioscience Announces Extension of Series A to $40 Million

Oct 19, 2022

PIC Therapeutics Completes $35 Million Series A Financing to Develop Treatments for Drug-Resistant Breast Cancer

Oct 14, 2022

Sen-Jam Pharmaceutical, the World's Most Resourceful Drug Innovator, Turns to Both Private and Institutional Investors to Secure Series A Financing to Further Advance Critical Therapeutics

Sep 28, 2022

Brandon Capital co-Leads USD68M Series A Financing of London-Based ADC Company Pheon Therapeutics

Sep 14, 2022

Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering

Jul 28, 2022

SEngine Precision Medicine closes Series A bringing total financing to $19M enabling continued advancement of personalized cancer treatments

Jul 13, 2022

Xilis Announces Series A Extension, Bringing Total Round to Over US$89 Million

Jul 12, 2022

Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding

Jul 12, 2022

Epic Bio, Founded by CRISPR Pioneer, Launches to Revolutionize Genetic Medicine With Epigenetic Engineering

Jul 7, 2022

Kernal Biologics Announces $25M Series A Financing to Advance its mRNA 2.0 Technology for Oncology

Jun 7, 2022

Code Biotherapeutics Raises Upsized and Oversubscribed $75 Million in Series A Financing to Develop Therapies for Debilitating Genetic Diseases

Jun 7, 2022

4BIO Capital Portfolio Company Code Biotherapeutics Closes Upsized and Oversubscribed $75 Million Series A Financing

May 19, 2022

Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers

May 10, 2022

Domain Therapeutics Raises $42m Series A Financing

May 10, 2022

Genascence Announces First Close in Series A Financing led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board

Apr 28, 2022

Kelonia Therapeutics Launches with $50 Million Series A Financing to Pioneer Precision Targeted Genetic Medicines

Apr 13, 2022

Versant Ventures Launches Cimeio Therapeutics with $50 Million Series A

Apr 7, 2022

Rona Therapeutics Announces Completion of $33 Million Series A Financing to Advance Global Discovery and Development of RNA Therapeutics

Mar 30, 2022

Altoida upsizes its Series A Round to $20.3M to Advance Its First in Class AI-Powered Neurocognitive Assessment Platform

Mar 29, 2022

RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines

Mar 17, 2022

Triumvira Immunologics Completes Extension of Series A Financing, for Total Round of Approximately $100 Million

Mar 16, 2022

KayoThera, Inc. Raises $8 Million in Series A Financing Led by Accelerator Life Science Partners to Develop Novel Cancer Immunotherapeutics

Mar 15, 2022

Eclipsebio Announces a $14 Million Series A Financing to Advance Its RNA Genomics Technology Platform

Mar 8, 2022

TRexBio Completes $26 Million Series A Extension Led by Polaris Partners to Advance Treatments for Immune-Mediated Diseases

Mar 1, 2022

Novo Holdings Portfolio Company Syndesi Therapeutics acquired by AbbVie

Feb 23, 2022

hC Bioscience Announces $24 Million Series A Financing to Develop Innovative Pipeline of Protein-Editing Therapies

Feb 23, 2022

Complement Therapeutics Ltd raises EUR 5 Million Seed Financing by BGV and Forbion and appoints Dr Rafiq Hasan as CEO

Feb 23, 2022

Mnemo Therapeutics Names Robert LaCaze as Chief Executive Officer

Feb 23, 2022

Mnemo Therapeutics Names Robert LaCaze as Chief Executive Officer USA - English Deutschland - Deutsch

Feb 16, 2022

Centauri Therapeutics Closes £24 Million GBP Series A Investment Round

Feb 15, 2022

Renibus Therapeutics Announces Appointment of Frank Stonebanks as CEO and $35 Million Series A Funding

Feb 10, 2022

Indapta Therapeutics Names Mark W. Frohlich, M.D., Chief Executive Officer and Raises Over $50 Million in Series A Financing and Commitments to Advance Development of G-NK Cell Therapy to Treat Multiple Types of Cancer

Feb 9, 2022

Seismic Therapeutic Launches with $101 Million Series A Financing to Usher in a New Era of Immunology Drug Development Integrating Machine Learning

Feb 1, 2022

Stemson Therapeutics Secures 15M Series A Funding to Cure Hair Loss

Jan 31, 2022

Gandeeva Raises $40M in Series A Funding to Develop Novel Therapies Based on Precision Imaging of Protein-Drug Interactions

Jan 25, 2022

Cytovation raises $20 million in Series A financing round to advance clinical development of CyPep-1, a first-in-class targeted tumor membrane immunotherapy

Jan 6, 2022

ONK Therapeutics Announces $21.5M Series A Financing to Advance Pipeline of Next-Generation Optimally Engineered Off-the-Shelf NK Cell Therapies

Jan 5, 2022

Avenge Bio Announces Closing of $45 Million Series A Financing

Dec 14, 2021

Phosplatin Therapeutics Announces $37 Million Series A Financing

Dec 9, 2021

Bloom Science Raises USD $12 Million in Series A Financing

Dec 9, 2021

Bloom Science Raises USD $12 Million in Series A Financing USA - English USA - español

Dec 9, 2021

K36 Therapeutics Launches with $30 Million Series A Financing from F-Prime Capital and Atlas Venture with Eight Roads Ventures

Dec 8, 2021

KeifeRx Completes $6 Million Series A Financing and Enhances Board of Directors

Dec 7, 2021

Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines

Dec 1, 2021

Trefoil Therapeutics Announces Third Tranche of $28 Million Series A Financing Based on Achievement of Clinical Trial Objectives

Nov 29, 2021

Ablaze Pharmaceuticals Launches with $75m Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market USA - English USA - español USA - Français USA - Deutsch

Nov 17, 2021

Chroma Medicine Launches with $125M in Financing to Deliver on the Promise of Epigenetic Editing

Nov 9, 2021

Novo Holdings and Lundbeckfonden Portfolio Company IO Biotech Closes Initial Public Offering on the Nasdaq Global Market

Nov 4, 2021

Cellenkos Inc. Secures $15 Million Series A Financing to Accelerate the Development of Transformation Cell-Based Therapies

Nov 4, 2021

Primmune Therapeutics Receives $8.4 Million in Second Tranche of Series A Financing

Nov 3, 2021

GRO Biosciences Announces $25M Series A Financing Led by Leaps by Bayer and Redmile Group

Nov 2, 2021

Nitrome Biosciences Appoints Pierre Beaurang, Ph.D., as Chief Executive Officer, Expands Series A to $45M, and Changes Company Name to Nitrase Therapeutics

Oct 26, 2021

Mozart Therapeutics Launches with $55 Million Series A Financing to Develop Disease Modifying Therapeutics for Autoimmune and Inflammatory Diseases USA - English España - español France - Français

Oct 26, 2021

Mozart Therapeutics Launches with $55 Million Series A Financing to Develop Disease Modifying Therapeutics for Autoimmune and Inflammatory Diseases USA - English USA - español USA - Français

Oct 14, 2021

Rectify Pharmaceuticals Launches with $100 Million Series A Financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund

Oct 12, 2021

AUM Biosciences announces closing of USD $27Million in a "Series A" Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies

Oct 7, 2021

ATP Unveils Non-Viral Gene Therapy Innovator Intergalactic Therapeutics with $75 Million in Series A Funding

Sep 27, 2021

Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders

Sep 21, 2021

858 Therapeutics Launches with Proven Team and $60 Million Series A Financing

Sep 16, 2021

Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing to Develop Next-Generation Non-viral Gene Therapies

Sep 9, 2021

Calypso Biotech Announces First Patient With Celiac Disease Dosed in anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 Phase 1b Trial, and Extension of Series A to €28M

Sep 9, 2021

Evommune Inc., Completes $83 Million Series A Financing to Advance Development of Unique Chronic Inflammation Pipeline

Sep 8, 2021

ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience

Aug 31, 2021

DGAP-News: Inotrem SA: Inotrem Raises EUR18 million to Develop Innovative Sepsis Treatments in a Series A Financing Co-led by Edmond de Rothschild Investment Partners and Sofinnova Partners

Aug 31, 2021

Versanis Bio Announces $70 Million Series A Financing to Advance Bimagrumab for the Treatment of Obesity

Aug 18, 2021

EpiEndo Pharmaceuticals Secures EUR 20 Million Series A Funding to Advance Clinical Development of its Non-Antibiotic Macrolide for the treatment of COPD

Aug 11, 2021

GentiBio Announces $157M Series A Financing to Advance Engineered Regulatory T cells as Transformative Therapeutics with Potential to Restore Immune Tolerance and Durably Treat Autoinflammation

Aug 3, 2021

Engrail Therapeutics Extends Series A Financing to $64 Million

Jul 28, 2021

Protera Announces Final Close of Its $10M Series A Led by Sofinnova Partners

Jul 27, 2021

IMIDomicsTM Closes $16.5 Million Series A Financing to Advance its Precision Discovery Platform for Immune-Mediated Inflammatory Diseases

Jul 27, 2021

Steven P. Cohen, Chief of Pain Medicine at Johns Hopkins, Joins Releviate Therapeutics as Head of Its Scientific Advisory Board

Jul 20, 2021

Rivus Pharmaceuticals Launches with $35 Million Series A Financing to Develop Novel Treatments for Cardio-Metabolic Diseases

Jul 15, 2021

PAQ Therapeutics Launches with $30 Million Series A to Develop Novel Therapies through Autophagy-Dependent Degradation

Jul 15, 2021

Stemson Therapeutics Secures $15M Series A Funding to Cure Hair Loss

Jul 12, 2021

ProfoundBio Announces Completion of More Than $55 million Series A Financing to Advance Novel Antibody-Drug Conjugate (ADC) Portfolio

Jul 9, 2021

Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases

Jul 9, 2021

Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases

Jul 8, 2021

Xilis Raises $70 Million Series A Financing to Advance Diagnostic and Drug Discovery and Development Platform Leveraging Proprietary MicroOrganoSphere™ Technology

Jun 30, 2021

ArriVent Biopharma Launches with Up To $150M in Series A Financing and Strategic Licensing Agreement for Clinical-Stage Oncology Asset

Jun 23, 2021

ImmuneID Announces Close of $50 Million Series A Financing to Develop Precision Immunology Therapeutics

Jun 23, 2021

Abata Therapeutics Launches to Usher in New Era of Cell Therapy Using Targeted Regulatory T Cells to Treat Serious Autoimmune and Inflammatory Diseases

Jun 23, 2021

Strand Therapeutics Raises $52M in Oversubscribed Series A Round

Jun 23, 2021

Vita Therapeutics Raises $32 Million in Oversubscribed Series A Financing Led by Cambrian Biopharma to Advance the Development of Therapies to Treat Muscular Dystrophies

Jun 22, 2021

TRexBio Closes the Final Tranche of $59 Million Series A Financing to Advance Innovation in Tissue Immunobiology for the treatment of Cancer and Inflammatory Diseases

Jun 17, 2021

Kite and Shoreline Biosciences Enter Into Strategic Partnership to Develop Novel Allogeneic Cell Therapies

Jun 17, 2021

PanTher Therapeutics Closes Oversubscribed $5.4M Series A Round, Expands Board of Directors, As Company Prepares to Initiate First Clinical Trial of Novel Localized Treatment of Pancreatic Cancer

Jun 17, 2021

LENZ Therapeutics Debuts With $47 Million Series A Financing

Jun 16, 2021

Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members

Jun 16, 2021

Mnemo Therapeutics Announces €75 million Series A to Accelerate Next Generation Integrated CAR-T and Epigenetic Targeting Platform USA - English USA - English USA - English España - español España - español USA - English USA - English France - Français France - Français Deutschland - Deutsch Deutschland - Deutsch

Jun 16, 2021

Mnemo Therapeutics Announces €75 million Series A to Accelerate Next Generation Integrated CAR-T and Epigenetic Targeting Platform USA - English USA - español Middle East - English USA - Français USA - Deutsch

Jun 10, 2021

Kurome Therapeutics Closes $15 Million Series A Financing to Develop Targeted Kinase Inhibitors for Treatment of Hematopoietic Cancers

Jun 10, 2021

Onchilles Pharma Raises $7 Million Series A to Advance Drug Candidates to Activate Newly Discovered Broad-Acting Anticancer Pathway

Jun 9, 2021

Kojin Therapeutics Launches with $60 Million Series A to Develop New Category of Drugs Based on Cell State Biology

Jun 3, 2021

Stablix Therapeutics Launches with $63 Million Series A Financing

Jun 3, 2021

Amyl Therapeutics closes €18.3 million Series A financing to develop novel therapies for Amyloidosis

Jun 3, 2021

Stellanova Therapeutics, Inc. Announces Closing of $15.5 Million Series A Financing

May 18, 2021

Vedere Bio II Launches with $77 Million Series A Financing to Develop Next Generation Ocular Gene Therapies

May 18, 2021

Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform

May 13, 2021

Flare Therapeutics Launches with $82 Million Series A Financing to Advance Precision Oncology Pipeline based on Novel Drug Discovery Approach for Transcription Factors

May 13, 2021

Kinnate Biopharma Inc. Closes $35 Million Series A Financing to Establish a Chinese Joint Venture

May 12, 2021

Juno Diagnostics Announces Closing of $25 Million Series A Financing Led by Perceptive Xontogeny Venture Fund

May 12, 2021

Perceptive Advisors Closes $515 Million Perceptive Xontogeny Venture Fund II, LP ​

May 6, 2021

Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AI‑powered Gene Therapy Platform

May 6, 2021

Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Merger to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation

May 6, 2021

Gilgamesh Pharmaceuticals Closes On $27 Million Series A Round

May 5, 2021

Eikon Therapeutics Closes $148 Million Series A Financing to Develop High-Throughput, Super-Resolution Microscopy for Drug Discovery

May 5, 2021

BridGene Biosciences Announces $12 Million Series A Financing to Advance the Company's Proprietary Chemoproteomic Platform and Pipeline of Oncology Programs

Apr 29, 2021

Adcendo raises EUR 51 Million in Series A Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Cancers

Apr 29, 2021

Capsida Biotherapeutics Debuts with $140 Million of Capital

Apr 29, 2021

Novo Seeds co-leads Adcendo's EUR 51 Million Series A Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Cancers

Apr 28, 2021

Adcentrx Therapeutics Announces Completion of $50m Series A Financing Led By CBC Group To Accelerate Next-Generation Conjugate Drugs Research and Development

Apr 20, 2021

OS Therapies Completes $6 Million Series A Funding Round

Apr 15, 2021

Alchemab raises £60M ($82M) in Series A financing to advance novel platform for identifying disease-modifying antibody therapeutics

Apr 15, 2021

Tectonic Therapeutic Launches with $80 Million Series A Financing to Transform the Discovery of Novel G-Protein Coupled Receptor (GPCR)-Targeted Therapies

Apr 8, 2021

ValenzaBio Advances Pipeline of Antibody Therapeutics Toward Clinical Development for Autoimmune and Inflammatory Diseases

Apr 7, 2021

Metagenomi Extends Series A Financing from RA Capital and Welcomes Andrew Levin to Its Board of Directors

Apr 6, 2021

Mineralys Therapeutics Closes $40 Million Series A Funding

Apr 2, 2021

Cellphire Therapeutics, Inc. Closes $15 Million Series A Funding Round Led by Simcah Management

Mar 31, 2021

Creating Next Generation Smart Cell Therapies: Outpace Bio Receives $30 Million in Series A Funding Led by ARTIS Ventures and Lyell Immunopharma Inc.

Mar 29, 2021

CORRECTING and REPLACING Fortis Therapeutics Closes $40 Million Series A Financing to Advance Novel Anti-CD46 Therapeutic to Treat Late-Stage Prostate Cancer and Multiple Myeloma

Mar 23, 2021

Stuart Therapeutics Completes its $11M Series A Round, led by InFocus Capital Partners, WARF and MiMo Capital

Mar 23, 2021

Asher Bio Launches with $55 Million Series A Financing Led by Third Rock Ventures to Discover and Develop Highly Specific Immunotherapies Using a Novel Technology Platform

Mar 22, 2021

XyloCor Therapeutics Completes Oversubscribed $41.9 Million Series A Financing To Advance Novel Gene Therapy Pipeline For Coronary Artery Disease

Mar 18, 2021

Aktis Oncology Announces $72M Series A Financing To Advance Breakthrough Radiopharmaceuticals To Treat Solid Tumors

Mar 15, 2021

VLP Therapeutics raises $16M Series A for cancer treatment vaccine RandD

Mar 9, 2021

Visus Therapeutics Announces $36 Million Series A Financing to Advance Development of Novel Presbyopia-Correcting Eye Drop

Mar 3, 2021

Janux Therapeutics Announces $56 Million Series A to Advance Novel Cancer Drug Candidates Using T Cell Engager (TRACTr) Technology

Mar 1, 2021

SalioGen Therapeutics Announces Closing of $20 Million Series A Financing to Support Advancing a Novel Genome Engineering Platform for Non-Viral Gene Therapy

Feb 23, 2021

Teon Therapeutics Completes $30 Million Series A Financing

Feb 16, 2021

Centessa Pharmaceuticals Launches with $250 Million Series A Financing and Unveils a New Kind of Pharmaceutical RandD Model

Feb 11, 2021

Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First “Off-the-shelf” Genomic Medicines

Feb 10, 2021

HemoShear Therapeutics Raises $40 Million in Series A Financing to Advance Rare Disease Portfolio

Feb 10, 2021

Notch Therapeutics Closes $85 Million Series A Financing to Develop Pipeline of Renewable Stem Cell-Derived Cancer Immunotherapies

Feb 3, 2021

Coya Therapeutics Completes Merger with Nicoya Health Inc. and Announces $10 Million Series A Financing to Advance Pipeline of Regulatory T cell Therapeutics Optimized for Neurodegeneration and Autoimmune Diseases

Feb 2, 2021

Bexson Biomedical Raises $4.8 Million In Oversubscribed Series A

Jan 28, 2021

Enthera Pharmaceuticals Extends Series A Financing, Raising a Total Of €35m

Jan 26, 2021

Nirogy Therapeutics Launches with $16.5 Million Series A Financing

Jan 14, 2021

NewAmsterdam Pharma Completes $196M (€160M) Series A Funding for Comprehensive Phase 3 Development Program

Jan 12, 2021

Primmune Therapeutics Announces Close of Series A Financing

Jan 8, 2021

ATP and Biolojic Design Launch Aulos Bioscience to Develop Highly Differentiated IL-2 Antibody Approach to Fighting Cancer USA - English USA - English USA - English España - español España - español Deutschland - Deutsch Deutschland - Deutsch France - Français France - Français

Jan 8, 2021

ATP and Biolojic Design Launch Aulos Bioscience to Develop Highly Differentiated IL-2 Antibody Approach to Fighting Cancer USA - English Israel - English USA - español USA - Deutsch USA - Français

Jan 7, 2021

LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies for Rare and Non-Rare Monogenic Diseases

Jan 7, 2021

Endeavor BioMedicines Launches with $62 Million Series A Financing and Mission to Reverse the Course of Devastating Pulmonary Disease

Jan 5, 2021

Aro Biotherapeutics Announces $88 Million Series A Financing to Advance Development of Centyrin-Targeted Genetic Medicines

Jan 5, 2021

IconOVir Bio Raises $77 Million in Series A Financing to Develop Next-Generation Oncolytic Viruses to Treat Solid Tumors

Dec 22, 2020

Neomorph, Inc. Announces $109 Million Series A Financing to Advance Proprietary Protein Degradation Platform and Programs

Dec 16, 2020

Neuron23™ Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Kleiner Perkins, and Redmile Group

Dec 10, 2020

Faze Medicines Launches With $81 Million Series A Financing to Leverage New Biology of Biomolecular Condensates to Treat Disease

Dec 2, 2020

Genesis Therapeutics Secures $52M Series A to Further Accelerate AI Innovation and to Launch Drug Discovery and Development Pipeline

Dec 1, 2020

Noema Pharma raises CHF54 million in Series A financing round led by Sofinnova Partners and Polaris Partners

Dec 1, 2020

Tallac Therapeutics Launches with $62 Million in Series A Financing to Advance Novel Immunotherapies for Cancer

Nov 30, 2020

Spotlight Therapeutics Closes $30M Series A Led by GV to Advance Pipeline of Non-viral CRISPR Gene Editing Biologics

Nov 30, 2020

Kinaset Therapeutics Launches with a $40M Series A Financing to Develop Novel Therapeutics for Respiratory Diseases and an Exclusive Global License Agreement with Vectura Group for KN-002 (VR588), a Novel Anti-Inflammatory

Nov 27, 2020

Eluminex Biosciences, an Ophthalmology-Focused Biotechnology Company, Announces Closing of $50 Million Series A Financing

Nov 18, 2020

Umoja Biopharma Launches with $53M Series A Financing to Develop Fully Integrated, Scalable, In Vivo Immunotherapy Platform

Nov 18, 2020

Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer

Nov 16, 2020

Nereid Therapeutics Launches: ATP $50M Series A NewCo Co-Founded with Brangwynne, Pioneer of Biomolecular Condensates Field

Nov 12, 2020

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

Oct 29, 2020

Elpis Biopharmaceuticals Debuts with Series A Funding and Establishment of Scientific Advisory Board

Oct 28, 2020

Citrine Medicine Advances Efforts to Create the Very First Rare Disease Ecosystem in China Through Strategic Partnership with Bioprojet to License Exclusive Rights for the Use of Orphan Narcolepsy Therapy Wakix (pitolisant)

Oct 27, 2020

Primmune Therapeutics Announces $27.4 Million Series A Financing

Oct 22, 2020

Be Biopharma Launches with $52 Million Series A Financing to Advance B Cells as Medicines

Oct 22, 2020

Allonnia Launches from Ginkgo Bioworks' Ferment Consortium with $40M Series A to Address Critical Problems in Waste Remediation with Synthetic Biology, Appoints Nicole Richards as CEO

Oct 22, 2020

Orbus Therapeutics Expands Series A Financing to $71 Million to Support Ongoing STELLAR Phase 3 Study in Rare Brain Cancer

Oct 22, 2020

Gene Therapy Company AavantiBio Launches with $107 Million Series A Financing from Perceptive Advisors, Bain Capital Life Sciences, RA Capital Management and Sarepta Therapeutics

Oct 14, 2020

RayzeBio Launches with $45 Million Series A to Advance Portfolio of Targeted Radiopharmaceuticals for Cancer Therapeutics

Oct 6, 2020

Federation Bio Launches with $50 Million Series A Financing and Expands Team to Pioneer Diverse Microbial Therapies

Oct 6, 2020

Walden Biosciences Launches to Transform the Treatment of Kidney Disease

Sep 30, 2020

Sonoma Biotherapeutics Expands Series A Financing to $70 Million and Appoints Key Executives to Advance Regulatory T-cell Therapies in Autoimmune and Degenerative Diseases

Sep 28, 2020

BioShin, Biohaven's Asia-Pacific Subsidiary, Raises $60M in Series A Funding to Advance Neuroscience Pipeline in Asia-Pacific Region

Sep 22, 2020

NeuroTherapia Closes $8.8M Series A Financing Led By Brain Trust Accelerator Fund II

Sep 17, 2020

Synthekine Launches with $82 Million Series A Financing to Advance Pipeline of Engineered Cytokine Therapeutics Optimized for Cancer and Autoimmune Diseases

Sep 16, 2020

Graphite Bio Launches with $45 Million Series A Financing

Sep 15, 2020

Hexagon Bio Closes $47 Million in Series A Financing to Advance Novel Oncology and Infectious Disease Therapies

Sep 14, 2020

Attralus Launches with $25 Million Series A Financing from venBio Partners to Transform Treatment for Patients with Systemic Amyloidosis

Sep 10, 2020

MiNA Therapeutics Secures £23 Million Series A Financing to Advance First-in-Class Activating RNA-Based Therapeutics

Sep 10, 2020

Korro Bio Closes $91.5 Million Series A Financing to Advance the Next Frontier in RNA Therapeutics

Aug 27, 2020

Bayer and Northpond Ventures Lead USD $55 Million Series A Financing Round for Triumvira Immunologics

Aug 27, 2020

Bayer and Northpond Ventures Lead USD 55 million Series A Financing Round for Triumvira Immunologics

Aug 6, 2020

T-knife Completes €66 Million Series A Financing to Develop Next-Generation T-Cell Therapies

Aug 6, 2020

Aerovate Therapeutics Emerges From RA Capital Incubator With $72.6 Million Funding for Potential Disease-Modifying Pulmonary Arterial Hypertension Therapy

Aug 6, 2020

T-knife Completes EUR 66 Million Series A Financing to Develop Next-Generation T-Cell Therapies

Aug 4, 2020

POINT Biopharma Announces Successful USD $20M Series A Financing to Bring Precision Radioligand Therapy to Cancer Patients

Aug 4, 2020

IgGenix Completes $10 Million Series A Financing

Jul 29, 2020

Nura Bio Launches to Discover and Develop Neuroprotective Drugs, Backed by $73 Million Series A Financing

Jul 29, 2020

Biotech Vico Therapeutics raises $31 million (€27 million) in Series A financing round to advance therapies for rare central nervous system diseases

Jul 28, 2020

Enthera Pharmaceuticals Raises €28 Million in Series A Financing to Advance Restorative Therapy for Type 1 Diabetes and Inflammatory Bowel Disease

Jul 22, 2020

Vesigen Therapeutics Launches with USD 28.5 Million Series A Investment Led by Leaps by Bayer and Morningside Ventures

Jul 21, 2020

Elevation Oncology Emerges from Stealth with $32.5M Series A to Develop Precision Medicines for Tumors Harboring Rare Genetic Driver Alterations

Jul 21, 2020

Forge Biologics Launches with $40 Million Series A Financing to Manufacture and Develop Gene Therapies

Jul 21, 2020

Selva Therapeutics Announces $3 Million Series A Financing to Advance a Novel Broad Spectrum Antiviral for Infectious Diseases, Including COVID-19

Jul 16, 2020

Adagio Therapeutics Launches With $50M Series A Financing to Advance the Development of Best-in-Class, Broadly Neutralizing Antibodies for Coronavirus Treatment and Prophylaxis

Jul 14, 2020

iOnctura Extends Series A to EUR 20.1M

Jul 9, 2020

Tranquis Therapeutics Launches with $30 Million Series A Funding to Advance Novel Immuno-Neurology Approach to Treating Neurodegenerative and Aging-related Diseases

Jun 26, 2020

Artiva Biotherapeutics Launches with $78 Million Series A Financing to Advance NK Cell Therapies to Treat Cancer

Jun 18, 2020

Engrail Therapeutics Raises $32 Million in Series A Financing

Jun 11, 2020

Cullinan Oncology and PDI Therapeutics Join Forces to Bring Novel, First-In-Class Immuno-Oncology Antibody into the Clinic through a $26M Series A Financing

Jun 9, 2020

NFlection Therapeutics Launches with $20M Series A Funding to Advance Lead Program in Neurofibromatosis

May 13, 2020

QurAlis raises $42 Million Series A Financing to Develop New Therapies for Amyotrophic Lateral Sclerosis (ALS)

May 6, 2020

Ventus Therapeutics Launches with $60 Million Series A

Apr 27, 2020

Actym Therapeutics Raises $34 Million Series A

Apr 27, 2020

ROME Therapeutics Launches to Develop Novel Therapies for Cancer and Autoimmune Diseases by Harnessing the Power of the Repeatome

Apr 23, 2020

SwanBio Therapeutics Announces Series A Expansion to Fund its Lead Program and Grow Pipeline in Gene Therapy for Neurological Diseases

Apr 1, 2020

Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy to Treat Parkinson Disease

Mar 31, 2020

Affinia Therapeutics Raises $60M in Series A Financing to Advance Rational Design AAV Platform and Transformative Gene Therapies

Mar 31, 2020

Zucara Therapeutics Announces US$21 Million Series A Financing

Mar 26, 2020

ReCode Therapeutics Raises $80 Million in Oversubscribed Series A Financing

Mar 25, 2020

Redpin Therapeutics secures initial closing of $15.5 million in Series A financing

Mar 4, 2020

Amunix Raises $73 Million in Series A Financing Led by Omega Funds

Mar 3, 2020

Lipidio Pharmaceuticals Launches with First Close of Series A Financing

Feb 6, 2020

Azafaros Completes EUR 25 Million Series A Financing to Advance Rare Metabolic Disorders Pipeline

Feb 6, 2020

Sonoma Biotherapeutics launches with $40 million in Series A funding to advance regulatory T cell therapy in autoimmune and degenerative diseases

Feb 3, 2020

Swiss Biotech STALICLA Announces Closure of USD 8M (CHF 7.7) for Second Tranche of Series A

Jan 23, 2020

iOnctura Raises EUR 15 Million in Series A Financing to Progress its Pipeline into Clinical Development

Jan 22, 2020

Immuneering Raises $20 Million in Oversubscribed Series A Funding

Jan 21, 2020

Calidi Biotherapeutics Secures Series A Investments to Advance Manufacturing

Jan 9, 2020

Jasper Therapeutics Announces Expansion of Series A Financing, Bringing Total Corporate Fundraising to More than $50 Million

Jan 9, 2020

Emergex Raises More Than US$11 Million in a Series A Round to Progress Its Pipeline of Set-Point Vaccines for Infectious Diseases

Dec 16, 2019

Immuneering Completes $17 Million Series A Financing

Dec 10, 2019

Quellis Biosciences Inc. Announces $17 Million Series A Financing

Dec 10, 2019

ImmunOs Therapeutics AG Raises CHF 15M in Series A Financing, Co-led by Pfizer Ventures and BioMedPartners, to Advance a Novel Immunotherapy Agent For Cancer Into Human Trials

Dec 10, 2019

Perceptive Advisors Closes Inaugural $210 Million Perceptive Xontogeny Venture Fund to Support Early-Stage Biotech Startups​

Dec 6, 2019

Jasper Therapeutics Launches with $35 Million Series A Financing to Develop and Commercialize Innovative Conditioning Agents and Therapies to Transform Curative Hematopoietic Cell Transplants

Dec 4, 2019

Civetta Therapeutics Announces $53 million Series A to Advance Lead Programs and Develop Proprietary Platform Targeting Propeller Proteins

Nov 28, 2019

ViGeneron announces closing of series A financing to drive development of next generation gene therapy pipeline

Nov 21, 2019

AN2 Therapeutics Launches with $12 Million in Series A Funding and Announces a Strategic Partnership with Brii Biosciences

Nov 20, 2019

Werewolf Therapeutics Launches with $56M Series A Financing to Develop Transformative Immuno-Stimulatory Cancer Medicines

Nov 13, 2019

X-Biotix Therapeutics Announces Corporate Progress and Successful Fundraise

Nov 7, 2019

Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases

Nov 5, 2019

A2 Biotherapeutics Emerges From Stealth Mode With $57M Series A to Develop a Pipeline of Selective Tumor Cell Therapeutics

Nov 5, 2019

A2 Biotherapeutics Emerges From Stealth Mode With $57M Series A To Develop A Pipeline Of Selective Tumor Cell Therapeutics

Nov 5, 2019

CODA Biotherapeutics Announces Series A Extension, Bringing Total Round to $34 Million

Nov 5, 2019

Shape Therapeutics, Inc. Raises $35.5M Series A Financing, Led by NEA and Announces the Formation of a World-Class Scientific Advisory Board, to Advance a First-in-Class RNA Editing Gene Therapy Platform Focused on Curing Genetic Diseases

Nov 5, 2019

Innovative Targeting Solutions and Former Amgen Executive Team up to Launch A2 Biotherapeutics With a $57 Million Series A

Oct 31, 2019

Pinteon Therapeutics Launches Phase 1 Trial of Novel Tau Antibody that Targets a Potent Driver of Neurodegenerative Disease

Oct 31, 2019

Shasqi Completes $10 Million Series A Financing

Oct 29, 2019

Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production

Oct 28, 2019

Oncology Start-Up Nuvation Bio Closes $275 Million Series A Financing Led by Omega Funds

Oct 17, 2019

ArsenalBio Launches With $85 Million Series A Financing to Advance New Paradigm to Discover and Develop Immune Cell Therapies

Oct 15, 2019

Azitra Completes $14 Million Series A Financing

Oct 3, 2019

Aeovian Pharmaceuticals Raises $37 Million Series A Financing to Advance Selective mTORC1 Inhibitors into the Clinic for Rare and Age-Related Diseases

Oct 2, 2019

SEngine Precision Medicine Raises $5.1 Million Series A to Advance Personalized Oncology Drug Discovery Platform

Sep 26, 2019

ZielBio Closes $25.1 Million Series A Financing

Sep 19, 2019

Boundless Bio Launches to Deliver Transformative Therapies to Patients with Difficult-to-Treat Cancers Driven by Extrachromosomal DNA

Aug 22, 2019

Chinook Therapeutics Raises $65 Million Series A Financing to Advance Precision Medicines for Kidney Diseases

Jul 31, 2019

Sermonix Pharmaceuticals Closes US$26 Million Series A Financing Round Led by WILD Family Office

Jul 18, 2019

Kronos Bio Completes $105 Million Series A Financing

Jul 18, 2019

Vida Ventures Co-Leads $105 Million Series A Financing for Kronos Bio

Jul 17, 2019

Pyxis Oncology Founded by Longwood Fund with Financing Led by Bayer

Jul 16, 2019

Trefoil Therapeutics Raises $28 Million Series A to Advance Engineered FGF-1 for the Treatment of Corneal Diseases

Jul 10, 2019

Osivax Secures EUR 8 Million of Financing through a Series A Round to Develop Novel Universal Flu Vaccines and Expand oligoDOM Technology Platform

Jun 19, 2019

Comet Therapeutics Raises $28.5 Million Series A Financing to Support Development of Treatments Built Around Its Novel CoEnzyme A Platform

Jun 5, 2019

OncoMyx Therapeutics Completes $25 Million Series A Financing

May 30, 2019

Altoida Raises $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality

May 22, 2019

Locana Raises $55 Million Series A Financing to Advance Portfolio of RNA-targeting Gene Therapies

May 20, 2019

STORM Therapeutics Extends Series A to GBP 30M (USD 38.43M) with New Investor, Seroba Life Sciences

May 18, 2019

Talaris Therapeutics, Inc. Announces $100M Series A Financing to Advance Its Novel, Allogeneic Cell Therapy Through Late-Stage Clinical Development

May 14, 2019

CinCor Pharma In-Licenses Aldosterone Synthase Inhibitor, CIN-107, and Closes $50 Million Series A Financing

May 13, 2019

ElevateBio Launches to Create and Operate a Portfolio of Highly Innovative Cell and Gene Therapy Companies

May 9, 2019

Sofinnova Partners Invests in Twentyeight-Seven Therapeutics

May 7, 2019

Confo Therapeutics Raises €30 Million in Series A Financing

May 7, 2019

Verve Therapeutics Founded to Protect Against Heart Disease Launches with $58.5 Million in Series A Funding Led by GV

May 6, 2019

Spiral Therapeutics Closes Series A Financing Totaling $5.6 Million

Apr 17, 2019

Nocion Therapeutics Announces $27 Million Series A Financing

Apr 10, 2019

Cullgen Receives $16 Million Series A Investment to Advance Pipeline of Targeted Protein Degraders

Apr 3, 2019

Dyne Therapeutics Launches with $50 Million Series A to Develop Targeted Therapies for Muscle Diseases

Apr 3, 2019

AgomAb Therapeutics Completes Euros 21m Series A Financing

Mar 8, 2019

Cerebral Therapeutics Raises Series A Extension Financing to Advance Clinical-Stage Drug Device Combination Therapy to Phase 3 Readiness for Adult Refractory Epilepsy

Feb 26, 2019

Ginkgo Bioworks Launches Motif Ingredients with $90 Million Series A Financing

Feb 21, 2019

Geneos Therapeutics Secures $10.5 Million in Series A Financing to Develop the Next Generation of Neoantigen-Targeting Cancer Immunotherapies

Feb 19, 2019

Gain Therapeutics SA Announces Closing of EU 2.5 Million Series A Financing to Develop Novel Brain-Penetrant Non-Competitive Pharmacological Chaperones for Rare Lysosomal Storage Diseases and CNS Indications

Feb 14, 2019

Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia

Feb 14, 2019

Passage Bio Launches with $115.5 Million Series A to Develop AAV-Delivered Therapeutics to Treat Rare Monogenic CNS Diseases

Feb 11, 2019

Grey Wolf Therapeutics completes £10 million ($14 million) series A financing with Andera Partners and Canaan to fund development of immuno-oncology therapies to increase tumour visibility

Feb 6, 2019

Frazier Healthcare Partners Launches Recida Therapeutics to Develop Novel Therapeutics for Serious Antibiotic-Resistant Infections

Jan 30, 2019

Dewpoint Therapeutics Launches with $60 Million Series A to Advance Proprietary Platform for Drugging Condensates

Jan 7, 2019

Apic Bio Announces $40M Series A Financing to Advance Novel Gene Therapies for Rare Genetic Disorders

Jan 3, 2019

Incysus Therapeutics Completes Series A Financing and Announces the Appointment of Travis Whitfill, MPH to Its Board of Directors

Dec 18, 2018

Spiral Therapeutics Announces First Closing of a Series A Financing and Begins Phase 1 Trial of New Hearing Loss Drug

Dec 18, 2018

Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform

Dec 18, 2018

Aristea Therapeutics Launches with Phase 2 Drug Candidate and $15M in Series A Funding from Novo Holdings A/S

Dec 6, 2018

XyloCor Therapeutics Raises $17 Million in Series A Financing to Advance Gene Therapy Portfolio in Cardiovascular Disease

Dec 5, 2018

Vast Therapeutics Announces Series A Funding

Dec 3, 2018

Tactiva Therapeutics Secures $35 Million Series A Financing to Pursue Clinical Development of DEACT Platform

Nov 27, 2018

Antios Therapeutics Raises $25 Million in Oversubscribed Series A Financing to Pursue Hepatitis B Cure

Nov 13, 2018

Ribometrix Announces $30 Million Series A Funding to Advance Pipeline of RNA-Targeting Small Molecule Therapies

Nov 8, 2018

Intrommune Therapeutics Announces First Close of Series A Preferred Equity Financing and Successful Close of Crowdfunding Financing Campaign to Support New Peanut Allergy Treatment

Nov 7, 2018

Mirum Pharmaceuticals Secures $120 Million in Series A Financing to Develop Phase 3-Ready Maralixibat for Rare Liver Diseases

Oct 30, 2018

Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer

Oct 29, 2018

Third Rock Ventures Launches Goldfinch Bio with $55 Million Series A Investment

Oct 25, 2018

89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing

Oct 23, 2018

Abilita Bio Appoints Dan Bradbury to its Newly Formed Board of Directors

Oct 22, 2018

Qpex Biopharma Announces Closing of $33 Million Series A Financing and Launch of Company to Address Worldwide Problem of Drug-Resistant Infections

Oct 17, 2018

CuraSen Therapeutics Announces $54.5 Million Series A Financing with Industry Veterans at Helm to Develop Drugs Targeting Novel Mechanism for the Treatment of Neurodegenerative Diseases

Oct 10, 2018

Gotham Therapeutics Launches with $54 Million Series A

Oct 1, 2018

Modis Therapeutics Announces $30M Series A Financing

Sep 27, 2018

Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture

Sep 27, 2018

AbCellera Closes Series A led by DCVC Bio

Sep 19, 2018

Silverback Therapeutics Extends Series A to $47.5 Million to Advance Pipeline of First-in-Class Systemically Delivered, Locally Active Therapies

Sep 6, 2018

Twentyeight-Seven Therapeutics Launches with a $65 Million Series A Funding

Aug 23, 2018

ApoGen Biotechnologies Expands Series A Financing to $11 Million and Enhances Leadership Team

Aug 13, 2018

Accelerator Life Science Partners Launches Magnolia Neurosciences Corporation with $31 Million Series A to Develop Targeted Neuroprotective Therapies

Aug 7, 2018

Akouos Raises $50 Million Series A Financing and Expands Team to Advance Precision Genetic Therapies That Restore and Preserve Hearing

Aug 2, 2018

Karuna Completes $42 Million Series A Financing Round to Advance Selective Muscarinic Receptor Agonist Program into Phase 2 Study

Jul 25, 2018

Inversago Pharma Receives $7 Million in Series A Financing

Jul 19, 2018

IFM Therapeutics, LLC Launches Subsidiary, IFM Tre, with $31 Million Series A Financing to Develop NLRP3 Antagonists for Inflammatory Diseases

Jul 17, 2018

HotSpot Therapeutics Completes $45 Million Series A Financing to Advance New Approach to Allosteric Drug Discovery

Jul 16, 2018

Verge Genomics Announces $32 Million Series A to Lead Artificial Intelligence-Driven Drug Discovery

Jul 12, 2018

Compass Therapeutics Completes $132 Million Series A Financing to Advance Next-Generation Antibody-Based Therapeutics into the Clinic

Jun 28, 2018

Appello Completes $10.5 Million Series A Financing Led by Deerfield Management and Mountain Group Partners

Jun 27, 2018

Carisma Therapeutics Announces a $53 Million Series A Financing to Develop Novel CAR Macrophage Cellular Immunotherapy

Jun 25, 2018

Akero Therapeutics Closes $65 Million Series A Financing to Advance New Treatments for Serious Metabolic Diseases

Jun 25, 2018

NodThera secures £28 million ($40 million) Series A Financing

Jun 20, 2018

Cerebral Therapeutics Raises Series A Financing to Advance Clinical-Stage Drug-Device Combination Therapy for Adult Refractory Epilepsy

Jun 11, 2018

Juvenescence Raises $50 Million in Series A Financing

May 31, 2018

CAMP4 Therapeutics Launches with Platform to Discover Effective Treatment Approaches for Every Disease, Announces $30 Million Series A Financing

May 25, 2018

Rallybio Established by Industry Leaders with $37.0 Million in Series A Financing to Develop Transformative Therapies for Patients with Severe and Rare Diseases

May 19, 2018

Tmunity Raises Additional $35 Million in Series A Financing, Bringing Series A Total to $135 Million to Advance Next-Generation T Cell Therapies

May 18, 2018

Accent Therapeutics Announces Company Launch with $40 Million Series A Financing for Novel, Precision Cancer Treatments Targeting RNA-Modifying Proteins

May 15, 2018

Celsius Therapeutics Launches with $65 Million in Series A Financing to Develop Precision Therapeutics for People with Autoimmune Diseases and Cancer

May 14, 2018

Ansun BioPharma secures $85 million in Series A Financing

May 14, 2018

MediSix Therapeutics Launches with USD$20M Series A Financing

May 9, 2018

Escient Pharmaceuticals Launches with $40 Million Series A Financing to Advance First-in-Class G Protein-Coupled Receptor (GPCR)-Targeted Drugs to Address Serious, Unserved Medical Needs

May 7, 2018

Neurana Pharmaceuticals Announces Completion of $60 Million Series A Financing

May 2, 2018

OnKure Close $7M Series A Financing to Support Development of Epigenetics Drug

Apr 30, 2018

Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough

Apr 24, 2018

X-Biotix Therapeutics, Inc. Secures $7 million in Series A Financing

Mar 22, 2018

Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism to Develop Precision Medicines for Immune-Mediated Diseases

Mar 8, 2018

Prevail Therapeutics Announces $75 Million Series A Financing to Advance Gene Therapies for Patients with Parkinson’s and Other Neurodegenerative Diseases

Mar 7, 2018

JW Therapeutics Closes $90 Million Series A Financing

Mar 7, 2018

Atomwise Raises $45 Million Series A to Become the Preferred Artificial Intelligence Partner for the Global Pharmaceutical Industry

Feb 27, 2018

Senti Biosciences Secures $53 Million Series A to Build the Future of Gene and Cell-Based Therapies

Feb 27, 2018

Quentis Therapeutics Debuts with $48 Million Series A Financing to Advance First-in-Class Immunotherapies Targeting Endoplasmic Reticulum Stress Response Pathways

Feb 15, 2018

ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-Resistant Bacteria USA - English España - español France - Français Deutschland - Deutsch

Feb 6, 2018

Xoc Pharmaceuticals Announces $30 Million Series A Financing Led by NEA

Jan 23, 2018

Tmunity Therapeutics Raises $100 Million in Series A Financing to Advance Portfolio of Next-Generation T cell Immunotherapies to Transform the Treatment of Cancer

Jan 18, 2018

Pandion Therapeutics Announces $58 Million Series A Financing to Advance Tissue-Specific Immune Modulator Drugs for Autoimmune and Inflammatory Diseases

Jan 8, 2018

STORM Therapeutics Extends Series A Round to Include New Investor Taiho Ventures

Jan 5, 2018

KBP Biosciences Raises $76 Million in Series A Financing and Appoints Brian P. McVeigh as Chief Executive Officer

Jan 4, 2018

Stoke Therapeutics Announces $40 Million Series A Financing to Create Pioneering New Medicines that Restore Gene Expression in Severe Genetic Diseases

Jan 4, 2018

Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept

Jan 3, 2018

Elstar Therapeutics Closes $39M Series A Financing to Support Development of its Universal Targeted Immunotherapy Platform

Jan 3, 2018

Expansion Therapeutics Raises $55.3 Million in Series A Financing to Advance Portfolio of Novel RNA Targeted Small Molecule Medicines to Treat Rare Diseases

Dec 14, 2017

Jnana Therapeutics Launches With $50 Million Series A Financing to Target the Cell’s Metabolic Gates

Dec 14, 2017

Kyn Therapeutics Announces $49 Million Series A Capital Available to Develop Cancer Therapy Candidates with Novel Approaches to Major Immunometabolism Pathways

Dec 14, 2017

Clover Biopharmaceuticals Completes RMB 62.8 Million Series A Financing

Dec 6, 2017

Obsidian Therapeutics Announces $49.5 Million Series A Financing to Develop Controllable Cell and Gene Therapy Products

Dec 6, 2017

Neumentum Raises $6 Million in Series A Funding to Develop Non-opioid Pain Products and Requests Type B Meeting with FDA

Nov 29, 2017

Frazier-backed Mavupharma secures $20M in Series A financing to fund STING program

Nov 29, 2017

Apexian Pharmaceuticals is Closing a Series A Round to Initiate Phase 1 Trial

Nov 21, 2017

Step Pharma Completes €14.5 Million Series A Financing with Additional New Investor

Nov 15, 2017

Outpost Medicine Appoints Scott Byrd as Chief Executive Officer and Raises $20 Million in Series A Financing Extension

Nov 14, 2017

Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team

Nov 14, 2017

Locus Biosciences Closes $19 Million Series A Led by ARTIS Ventures for CRISPR-Cas3 Antimicrobials

Nov 2, 2017

Klotho Therapeutics, Inc. Targets Kidney Disease with Series A Financing

Oct 30, 2017

Kymera Therapeutics Announces Series A to Advance Novel Therapeutic Modality and Develop Innovative Therapies

Oct 17, 2017

Gemini Therapeutics Announces $42.5 Million Series A Financing to Develop Precision Therapeutics in Ophthalmology and Rare Genetic Diseases

Oct 12, 2017

Spruce Biosciences Provides Corporate Update on Series A Venture Financing, Leadership Team and Lead Clinical Program

Oct 3, 2017

Cullinan Oncology Secures $150 Million Series A Financing to Build Innovative Development Company

Sep 27, 2017

Engage Therapeutics Announces $23 Million Series A Financing to Advance Phase 2b Development of Novel Epileptic Seizure Rescue Therapy

Sep 26, 2017

Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome

Sep 25, 2017

Fusion Pharmaceuticals Completes Oversubscribed Series A Financing Totaling $46 Million USD to Develop Targeted Alpha Therapeutics

Sep 25, 2017

SpringWorks Therapeutics Launches with $103M in Series A Funding and Rights to Four Clinical Programs

Sep 25, 2017

FACIT Congratulates Portfolio Company Fusion Pharmaceuticals on its US$46 Million Oversubscribed Series A

Sep 21, 2017

Landos Biopharma Raises $10 Million in Series A Financing

Sep 19, 2017

Disarm Therapeutics Unveils Breakthrough Approach to Treat Patients with Neurological Diseases by Preventing Axonal Degeneration

Sep 18, 2017

LifeMine Therapeutics Launches with $55 Million Series A Financing

Sep 14, 2017

Bayer and Ginkgo Bioworks join forces for sustainable agriculture, forming new company with USD 100 million Series A

Sep 14, 2017

Grid Therapeutics Closes Series A Financing

Aug 23, 2017

Macrophage Pharma Limited Extends Series A Round to Include New Investor Merck Ventures

Jul 27, 2017

Petra Pharma Appoints Executive and Scientific Leadership Teams

Jul 25, 2017

Accelerator Corporation Announces Series A Financing in Rodeo Therapeutics to Focus on Small-Molecule Regenerative Therapies

Jul 20, 2017

NeuroVia Closes Series A Financing Round of $14M to Develop Novel Treatment Option for X-ALD Disease

Jul 12, 2017

E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline

Jun 29, 2017

Indi Molecular Raises $11.5M Series A to Accelerate PCC Platform Development

Jun 22, 2017

Repare Therapeutics Raises US$68 Million Series A

Jun 14, 2017

Orum Therapeutics Raises $8 Million Series A Financing to Advance Cell-Penetrating Antibody Technology for Novel Cancer Therapeutics

May 25, 2017

Circle Pharma Announces Expansion of Series A Financing and Appointment of James C. Lu to Its Board

May 25, 2017

EpimAb Biotherapeutics Raises $25M in Series A Financing From International Consortium to Advance Pipeline of Novel Bispecific Antibodies

May 24, 2017

OrphoMed Secures $39 Million Series A Financing Round

May 24, 2017

OrphoMed Secures $39 Million Series A Financing Round India - English USA - English France - Français Deutschland - Deutsch España - español

May 18, 2017

Xontogeny, a New Accelerator Operating Company, Launches with a $25 Million Series A Financing to Advance Early Stage Life Sciences Technology through Clinical Proof-of-Concept

May 15, 2017

BiomX Raises $24 Million in Series A Funding to Develop Microbiome Therapeutics

May 13, 2017

Lyndra, Inc. Raises $23 Million in Series A Financing to Advance Ultra-Long Acting Oral Therapeutic Delivery

May 11, 2017

Frequency Therapeutics Announces $32 Million Series A Financing to Support Clinical Development of a First-in-Class Hearing Restoration Therapeutic

May 10, 2017

Fulcrum Therapeutics Announces Additional Series A Financing from GV

May 4, 2017

Vivet Therapeutics Raises €37.5 Million in Series A Financing Round to Advance Novel Gene Therapies for Treating Inherited Metabolic Diseases

Apr 25, 2017

Forge Therapeutics Raises $15M Series A Financing to Develop First Novel Gram-Negative Antibiotic in Decades

Apr 11, 2017

Cirius Therapeutics Completes $40 Million Series A Financing to Fund Phase 2b Study of MSDC-0602K in NASH, Adds to Executive Team

Apr 11, 2017

TargEDys Extends Series A and Appoints New Board Members

Apr 11, 2017

TargEDys Extends Series A and Appoints New Board Members Deutschland - Deutsch France - Français España - español USA - English

Mar 30, 2017

Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment

Mar 16, 2017

eGenesis Announces $38 Million Series A Financing, Led by Biomatics Capital and ARCH Venture Partners, to Solve Shortage of Organs for Donation

Mar 9, 2017

OncoResponse Announces Final Closing of $22.5M Series A Financing Round

Feb 27, 2017

Arrakis Therapeutics Announces $38 Million Series A Financing to Target RNA with Small-Molecule Medicines and Names Michael Gilman Chairman and CEO

Feb 23, 2017

Fusion Pharmaceuticals Launches with a $25M USD Series A Financing to Develop Targeted Radiotherapeutics as Cancer Treatments

Feb 23, 2017

FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A Led by Johnson & Johnson Innovation

Feb 23, 2017

Finch Therapeutics Announces Strategic Collaboration with OpenBiome to Develop Microbiome Therapies for FDA Approval

Feb 22, 2017

PMV Pharma Secures $74 Million in Series B Financing for Cancer Drugs Targeting p53

Feb 15, 2017

Surrozen Launches Into Regenerative Medicine With $33 Million in Series A Financing Led by The Column Group

Feb 6, 2017

Chondrial Therapeutics Secures Up to $22.6 Million in Series A Financing and Licenses Novel Technology for the Treatment of Friedreich's Ataxia

Feb 2, 2017

Vividion Therapeutics, Inc., Launches With $50 Million Series A Financing

Jan 12, 2017

OncoImmune Announces Series A Financing

Jan 9, 2017

Macrophage Pharma Raises £9 Million in Series A Financing and Acquires Immune-oncology Technology Platform

Jan 6, 2017

Cavion Raises $26.1 MM Series A Financing

Jan 5, 2017

BlackThorn Therapeutics Secures $14 Million in Series A Extension Financing

Jan 5, 2017

Therachon Appoints Luca Santarelli, M.D., as Chief Executive Officer and Extends Series A Financing

Dec 21, 2016

Circle Pharma, Developer of Macrocyclic Peptide Therapeutics, Announces Series A Financing and Appoints Walter H. Moos, Ph.D., to Its Board

Dec 20, 2016

REVOLUTION Medicines Raises Additional $25 Million in Series A Financing

Dec 15, 2016

Oncorus®, Inc. Announces Additional Series A Financing Support From Astellas Venture Management LLC

Dec 12, 2016

Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing

Dec 12, 2016

Accelerator Corporation Announces $7M Series A Investment in ApoGen Biotechnologies to Develop a New Class of Drugs Targeting Resistance to Cancer Therapy

Nov 30, 2016

Axial Biotherapeutics Launches to Treat Patients with CNS Disorders by Harnessing the Gut Microbiome

Nov 29, 2016

Tetra Discovery Partners Raises $10 Million through Series A Financing and Two National Institutes of Health Grants

Nov 29, 2016

Nohla Therapeutics Announces Closing of $43.5M Series A Financing to Transform Stem Cell Transplantation with Innovative Off the Shelf, Universal Donor Cellular Therapy

Nov 22, 2016

Recursion Raises Additional Funding, Bringing Total Series A to $15.05M for Drug Discovery

Oct 20, 2016

BlackThorn Therapeutics Launches to Develop Novel, Targeted Treatments for Neurobehavioral Disorders

Oct 10, 2016

OncoResponse Secures $7M in Supplemental Series A Funding

Sep 27, 2016

Fortis Therapeutics Closes $18 Million Series A Financing to Advance New Antibody Drug Conjugate Therapies for the Treatment of Late-Stage Cancers

Sep 21, 2016

Artios Pharma Company Launch and Fundraising of $33.2 Million to Focus on Novel DNA Damage Response (DDR) Cancer Therapies

Sep 15, 2016

Eyevensys Announces Series A Extension Bringing Total Capital Raised to €9 Million

Sep 14, 2016

Third Rock Ventures Launches Relay Therapeutics with $57 Million Series A Financing to Create Breakthrough Medicines Based on Protein Motion

Sep 14, 2016

Delinia Announces $35 Million Series A Financing to Advance Novel Therapeutics Targeting Regulatory T Cells for Autoimmune Diseases

Sep 11, 2016

Inflazome closes US$17m Series A financing round from Novartis Venture Fund and Fountain Healthcare Partners to develop treatments for chronic inflammatory diseases

Sep 1, 2016

Immune-Onc Therapeutics, Inc. Announces $7 Million Series A Financing

Aug 29, 2016

CBT Pharmaceuticals Closes $9.75 Million Series A Financing Led by OrbiMed for Development of Oncology Pipeline

Aug 16, 2016

Oculis Completes Series A Financing

Aug 1, 2016

Bioniz Therapeutics Closes Series A Financing and Appoints David Pyott as Chairman of the Board of Directors

Jul 19, 2016

Oncorus®, Inc. Launches with $57 Million Series A Financing

Jul 19, 2016

Third Rock Ventures Launches Fulcrum Therapeutics with $55 Million Series A Investment

Jul 3, 2016

Innovative Biotech Company CStone Pharmaceuticals Receives 150 million Dollars in Series A Financing to Focus on Addressing the Specific Needs of Chinese Patients

Jun 30, 2016

Morphic Therapeutic Announces $51.5 Million Series A Financing to Develop Next-Generation Integrin Therapies

Jun 29, 2016

Vidac Pharma Completes $9 Million Series A Financing

Jun 22, 2016

IFM Therapeutics Raises $27 Million Series A Financing Led by Atlas Venture and Abingworth

Jun 10, 2016

AiVita Biomedical Raises $2m in Series A Financing for Commercial and Clinical-Stage Program Development

May 17, 2016

Nouscom Concludes Successful Series A Financing of EUR 12 Million

May 17, 2016

Nouscom Concludes Successful Series A Financing of EUR 12 Million España - español USA - English France - Français Deutschland - Deutsch

May 14, 2016

Cydan Development Announces Formation of Imara Inc. with $31M Series A Funding to Develop Therapeutic for Sickle Cell Disease

May 3, 2016

IDEAYA Biosciences Raises $46 Million Series A and Recruits Leadership and Advisory Board

Apr 4, 2016

Cancer Metabolism Company Metabomed Completes $18 Million Series A Financing

Mar 29, 2016

Gadeta Closes EUR 7 Million Series A Financing to Advance Novel Cancer Immunotherapies to the Clinic

Mar 14, 2016

Takeda and Frazier Healthcare Partners Launch Outpost Medicine to Develop New Therapeutics in Urology and Gynecology

Mar 8, 2016

Capella Bioscience Completes Series A Financing of £11 million ($15.5 million) to Progress Antibody Pipeline

Mar 8, 2016

ImmunoMet Therapeutics Raises $5.2 million in a Series A Financing

Feb 22, 2016

Neurelis Finalizes Series A Financing to Advance Lead Program to NDA Filing

Feb 18, 2016

Third Rock Ventures Launches Pliant Therapeutics with $45 Million Series A to Treat Fibrotic Diseases

Feb 17, 2016

Corvidia Therapeutics Raises $26M in a Series A Financing, Led by Sofinnova Partners and Apple Tree Partners

Feb 10, 2016

Yumanity Therapeutics Closes $45 Million Series A Financing

Jan 27, 2016

Adicet Bio Announces Closing of $51 Million Series A Financing and Acquisition of Applied Immune Technologies

Jan 11, 2016

Accelerator Corporation Launches Lodo Therapeutics with $17 Million Series A to Develop Therapies Derived from Natural Products

Jan 7, 2016

C4 Therapeutics Launches with $73 Million Series A Financing

Dec 16, 2015

Poseida Therapeutics Announces Series A Financing

Dec 16, 2015

Hallux Announces Closing of $7.1 Million Series A Financing

Dec 10, 2015

Kallyope Inc. Launches With $44M Series A Financing To Harness The Potential Of The Gut-Brain Axis

Nov 4, 2015

Atreca, Inc., Completes Oversubscribed $56 Million Series A Funding to Advance Pipeline of Novel Cancer Immunotherapies

Oct 28, 2015

Versant Ventures Leads Series A in Turnstone Biologics Continuing Global Strategy to Access Innovation

Oct 28, 2015

Turnstone Biologics Completes Series A Financing Led by Versant Ventures, Strengthens Management Team

Oct 28, 2015

MabSpace Biosciences Secures $15 Million in Series A Financing From Lilly Asia Ventures

Oct 15, 2015

Third Rock Ventures Launches Decibel Therapeutics with $52 Million Series A Financing to Discover New Medicines to Protect, Repair and Restore Hearing

Oct 12, 2015

Patara Pharma Closes a $26 million Series A Financing and Initiates Phase II Clinical Trials to Evaluate PA101B for Refractory Chronic Cough and Indolent Systemic Mastocytosis

Oct 6, 2015

Oncoceutics Closes Series A Financing for First-in-Class Cancer Drug

Sep 21, 2015

leon-nanodrugs GmbH Starts U.S. Operations and Appoints Industry Veteran Theron (Ted) Odlaug as Chief Executive Officer

Aug 19, 2015

Orbus Therapeutics Secures $32.5 Million Series A Financing to Advance Late-Stage Brain Cancer Drug

Aug 17, 2015

Evolve BioSystems Inc. Completes $9 Million Series A Investment

Aug 12, 2015

Checkmate Pharmaceuticals Debuts with $20 Million Series A Investment for Development of Novel Immuno-Oncology Product Platform

Jul 27, 2015

leon-nanodrugs GmbH Raises EUR 18.5 Million in Series A Financing

Jul 27, 2015

Aspyrian Therapeutics Inc. Closes $4.25M Series A Extension Financing to Support the Execution of Phase 1 Clinical Studies of the Precision Targeted Cancer Therapy, RM-1929, to Treat Late-Stage Recurrent Head and Neck Cancers

Jul 21, 2015

Dauntless Pharmaceuticals Launches New Company Focused on Developing a Portfolio of Improved Therapeutics

May 15, 2015

OMEICOS Therapeutics Raises EUR 6.2 Million in Series A to Advance Lead Candidate in Atrial Fibrillation

May 11, 2015

Precision BioSciences Announces $25.6 Million Series A Financing

May 8, 2015

Alzheon Announces $10 Million Series A Financing

May 7, 2015

Spyryx Biosciences Secures $18 Million in Series A Financing

May 2, 2015

Caribou Biosciences Raises $11 Million in Series A Funding

Mar 24, 2015

Rigontec GmbH Raises €4.8m in a Second Closing of its Series A Financing

Mar 10, 2015

Madison Vaccines Announces Program Expansions for Its Investigational Prostate Cancer Vaccines

Mar 4, 2015

Macrolide Pharmaceuticals, Inc. Launches with $22 Million Series A Financing to Develop Novel Macrolide Antibiotics

Feb 26, 2015

Lyric Pharmaceuticals Announces $20.4M Series A Funding Round

Feb 4, 2015

Third Rock Ventures Launches REVOLUTION Medicines with $45 Million Series A to Redesign Evolution’s Products to Treat Serious Diseases

Feb 3, 2015

Lysosomal Therapeutics Inc. Raises $20 Million in Series A Financing

Jan 7, 2015

Leading Life Science Syndicate Commits $25 Million to Series A Funding to Launch Vtesse, Inc., the First Rare Disease Company Spun Out of Cydan Development, Inc. Deutschland - Deutsch France - Français USA - English España - español

Jan 5, 2015

Symic Biomedical Secures $15 Million in Series A Financing

Dec 8, 2014

Adagene Inc. Closes $8 Million Series A Financing with Fidelity Biosciences, Fidelity Asia Growth, and WuXi Venture Fund

Dec 2, 2014

PMV Pharma Announces $30 Million Raised in Series A Financing

Oct 14, 2014

Raze Therapeutics Launches with $24 Million Series A Financing to Advance a New Class of Oncology Therapeutics Targeting Metabolic Pathways Essential to Cancer Growth and Survival

Oct 14, 2014

Rigontec GmbH Raises €9.45m in a First Closing of a Series A Financing Round to Advance RNA-based Immunotherapeutics for Cancer and Viral Diseases

Jun 19, 2014

Navitor Pharmaceuticals Launches with $23.5 Million Series A Financing for Novel Drug Discovery Targeting Cellular Nutrient Signaling to Treat Chronic Diseases and Rare Disorders

Jun 12, 2014

Chrono Therapeutics, Inventor of Wearable "Smart" Smoking Cessation Technology, Secures $32 Million in Series A Financing

Apr 3, 2014

EMBL Ventures Invests £2M ($3.3M) in a Second Close of Crescendo Biologics' Series A Financing

Feb 20, 2014

OrthoTrophix Initiated Phase 2 Clinical Trial of a New Cartilage Repair Therapeutic for Knee Osteoarthritis and Closed Series A Financing

Jan 13, 2014

Madison Vaccines Closes $8 Million Series A Financing

Dec 17, 2013

Crescendo Biologics Raises £17.5M ($28M) in Series A Financing

Oct 23, 2013

F-star Announces Formation of New Asset-Centric Vehicle, F-star Alpha Ltd, with €9.4m Series A investment

Jun 5, 2013

Second Genome Announces Agreement with Janssen on Microbiome Drug Discovery in Ulcerative Colitis

May 20, 2013

eFFECTOR Therapeutics Raises $45 Million in Series A Financing

Apr 9, 2013

Cleave Biosciences Adds New Investor and $10 Million to Series A Financing

Feb 22, 2013

Blaze Bioscience Announces Completion of Series A Financing - Brings Total Investment to $9.8 Million

Dec 18, 2012

Trevi Therapeutics Announces $10 Million Series A Financing from TPG Biotech

Nov 29, 2012

ArmaGen Technologies, Inc. Announces $17 Million Series A Financing

Nov 9, 2012

Visterra Secures Financing From Gates Foundation and Omega to Close $26M Series A Financing

Jun 8, 2012

Blaze Bioscience Raises $5.0 Million in Series A Financing

May 17, 2012

Alcresta Launches Innovative Enzyme-Based Nutritional Company; Secures $10 Million Series A Round

Dec 13, 2011

ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease

Oct 11, 2011

Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies

Aug 15, 2011

Embera NeuroTherapeutics Closes on $4.5 Million Continuation of Series A Financing

Jul 27, 2011

Peloton Therapeutics Completes $18 Million Series A Financing

Jan 4, 2011

PanOptica Raises $30 Million in Series A Financing and Licenses Lead Compound for Development as Topical Treatment of AMD

Sep 22, 2008

Tech Coast Angels Closes Series A Financing for Amplyx Pharmaceuticals

Feb 4, 2008

Promedior Adds to Management Team and Announces Extension of Series A Financing